Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04314271
Other study ID # 202003028
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 20, 2020
Est. completion date May 31, 2020

Study information

Verified date March 2020
Source Xiangya Hospital of Central South University
Contact Zhao Ch Guang, MD
Phone +86136673520046
Email 562122649@qq.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Complete the examination of cardio-pulmonary ultrasound in accordance with the a-ccue process of patients with novel coronavirus bedside. To summarize and analyze the characteristics of cardiopulmonary ultrasound in patients with novel coronavirus pneumonia, and assess the relationship between pulmonary ultrasound imaging score and National Early Warning Score(NEWS) and prognosis. Auto line B is a method which is based on artificial intelligence is used to calculate the lungs ultrasonic B line numbers reviewing the status of patients with lung, and also evaluate patients' lungs using the traditional artificial semi-quantitative method, to evaluate those two kinds of evaluation methods for the evaluation of patients with lung condition effects are consistent or not, and verify consistency of ultrasonic evaluation method and the way of CT evaluation.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date May 31, 2020
Est. primary completion date May 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. age >18 years old

2. identify the patients infected with novel coronavirus pneumonia;

3. the patient completed CT examination;

4. sign the informed consent.

Exclusion Criteria:

1. age < 18;

2. those who cannot complete cardiopulmonary ultrasound according to the a-ccue process;

3. the patient or his guardian requests to withdraw from the researcher;

Study Design


Locations

Country Name City State
China Xiangya Hospital, Central South University Changsha Hunan

Sponsors (1)

Lead Sponsor Collaborator
Xiangya Hospital of Central South University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other evaluate two kinds of evaluation methods for the evaluation of patients with lung condition effects are consistent or not, and verify consistency of ultrasonic evaluation method and the way of CT evaluation. Auto line B is a method which is based on artificial intelligence is used to calculate the lungs ultrasonic B line numbers reviewing the status of patients with lung, and also evaluate patients' lungs using the traditional artificial semi-quantitative method, to evaluate those two kinds of evaluation methods for the evaluation of patients with lung condition effects are consistent or not 3 hours
Primary characteristics of cardiopulmonary ultrasound Complete the examination of cardio-pulmonary ultrasound in accordance with the a-ccue process of patients with novel coronavirus bedside. To summarize and analyze the characteristics of cardiopulmonary ultrasound in patients with novel coronavirus pneumonia 30 mins
Secondary assess the relationship between pulmonary ultrasound imaging score and National Early Warning Score(NEWS) and prognosis. assess the relationship between pulmonary ultrasound imaging score and National Early Warning Score(NEWS) and prognosis. 2-3weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04798716 - The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 Phase 1/Phase 2
Completed NCT05305456 - Clinical Trial Scheme of Tanreqing Capsules in the Treatment of COVID-19 Phase 3
Recruiting NCT04282902 - A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection Phase 3
Withdrawn NCT04285190 - The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19 N/A
Recruiting NCT04283396 - Study for Novel Coronavirus Pneumonia (NCP)
Active, not recruiting NCT04273763 - Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) N/A
Completed NCT04280224 - NK Cells Treatment for COVID-19 Phase 1
Completed NCT04273321 - Efficacy and Safety of Corticosteroids in COVID-19 N/A
Enrolling by invitation NCT04365309 - Protective Effect of Aspirin on COVID-19 Patients Phase 2/Phase 3
Completed NCT04645407 - Effects of Fuzheng Huayu Tablets on COVID-19 Phase 4